FunPep Company Limited
4881・Growth Market・Pharmaceuticals
Governance
Company with a Board of Corporate Auditors. The Board of Directors consists of 5 members (2 outside directors, outside director ratio of 40%), and all 3 corporate auditors are outside auditors. The Board of Directors met 17 times during the fiscal year under review, with all directors attending every meeting. No nomination committee or compensation committee has been confirmed to be established.
Risk Management
Risks are classified into 11 categories (product manufacturing/sales, asset management, systems, administrative operations, reputation, disasters/emergencies, legal matters, overseas business, information leakage, infringement of patent rights, and financial reporting), with a framework established based on the
Shareholder Returns
No dividends have been paid since establishment. The company is in a stage of upfront investment in research and development, and its policy is to prioritize securing R&D funding rather than paying dividends for the time being. It recognizes shareholder returns as an important issue and has indicated a stance of considering future dividends while taking into account business performance and financial condition.
Dividend Policy
The basic policy is to pay a year-end dividend and, depending on business performance, an interim dividend; however, as the company is currently in a stage of upfront R&D investment, no dividends have been paid since establishment. For the time being, the policy is to prioritize securing funds for continued R&D and not to pay dividends. Going forward, the company will consider profit distributions while taking into account its business results and financial condition.
ESG
The company links its Mission to SDG 3 ("Good Health and Well-Being"), positioning the Pharmaceutical Research & Development Business as a sustainability-related business opportunity. On the human capital front, it has established flextime and remote work systems to promote work-life balance. Quantitative ESG indicators and targets have not yet been set, and the company continues to consider the necessity of establishing them.
Last updated: March 24, 2026